Clinical Trial

Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints

Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials

Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients

Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials

Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients

Federal Money To Support Research On Psychedelics As Alternative To Pills For Chronic Pain Among The Elderly

Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments

Federal Money To Support Research On Psychedelics As Alternative To Pills For Chronic Pain Among The Elderly

Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments

Game Changing Move? NFL Tackles Pain And Concussions In CBD Clinical Trial Partnership With Canadian University

Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation

Clinical Trial Recent News

Canadian Government Granting $3M For Clinical Trials For Psilocybin-Assisted Psychotherapy

The quest to advance psychedelic medicine in Canada received a big boost today.

Cybin: Positive Clinical Trial On Psilocybin Analog For Major Depression & Updates On DMT Analog Program

Psychedelics biotech company Cybin Inc.

First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval

The partnership leading the way on psilocybin therapy for Fragile X Syndrome (FXS), the major genetic cause of Autism Spectrum Disorder (ASD), has received approval from Health Canada in the form of a No Objection letter and is set to proceed with the first-ever Phase 2a clinical trial on the magic mushrooms therapy for this condition.

Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug

Atai Launches Phase 1 Clinical Trial On Novel Direct-To-Brain Drug Delivery Technology

Clinical stage biopharma company atai Life Sciences (NASDAQ: ATAI) announced the initiation of the Phase 1 proof-of-concept (PoC) clinical trial of intranasal INB-01, a sol-gel based, excipient (

Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment

Cannabinoid-focused biopharmaceutical company Greater Cannabis Company, Inc. (OTC: GCAN) has submitted a clinical trial application to the Israel Ministry of Health for approval of Phase 2 clinical trial for its novel neuropsychiatric cannabinoid therapy.

Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment

Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) has set up a clinical research program for the treatment of strokes, focused on its proprietary DMT analogue, AP-188. The company is also planning to begin a Phase 1 clinical trial in 2022’s fourth quarter.

Cannabis Goes Head-to-Head With Big Pharma In New Zelira Therapeutics Pain Med Study

Zelira Therapeutics (OTC: ZLDAF), a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, is about to begin a first-ever clinical trial of its own proprietary pain formula for the treatment of diabetic nerve pain against an as-y

How To Enroll In A Psychedelic Clinical Trial In 5 Easy Steps

This article was originally published on Psychedelic Spotlight and appears here with permission. If you fail to meet even one of the inclusion criteria, or you meet even one of the exclusion criteria, then you are not eligible and you will not be selected for participation.

Charlotte's Web: Positive Results In Clinical Trial Of Hemp-Derived CBD For Stress, Sleep And Well-Being

Charlotte's Web Holdings, (TSX:CWEB) (OTCQX: CWBHF) reported positive results from a randomized, controlled, clinical trial study which evaluated the effectiveness of its hemp-derived CBD extracts.

MindMed Successfully Completes Phase 1 Trial Of 18-MC

This article was originally published on Microdose and appears here with permission.

MindMed Leverages Ayahuasca's Ingredient DMT In Psychedelic-Inspired Therapies, Launches Trials With 30 Subjects

Psychoactive brew ayahuasca is known for having a fast-onset antidepressant effect. With serotonergic psychedelics, such as ayahuasca, giving promising results in the quest for alternative treatments for depression and anxiety, many companies are turning their focus to developing psychedelic-inspired therapies.

MindMed Begins First-Ever Clinical Trial On MDMA, LSD Combinations

Mind Medicine (MindMed) Inc (OTC: MMEDF), a medicine biotech company in psychedelics, on Wednesday announced its start of the first-ever clinical trial measuring and evaluating 3,4-methylenedioxymethamphetamine (MDMA) and lysergic acid diethyl

Why Supernus Shares Rallied 24% After-Hours On Tuesday

Supernus Pharmaceuticals Inc (NASDAQ: SUPN) announced Monday that its SPN-812 — a commercial treatment for patients with Attention Deficit Hyperactivity Disorder (ADHD), exhibited positive topline results in late-stage trials.

Emerald Health Pharmaceuticals To Raise $17M Via New Reg A+ Round

Emerald Health Pharmaceuticals Inc. (EHP) is launching a new financing round under its Regulation A offering. The round will open on Monday, Dec. 7, and expire on Mar. 28, 2021, or upon raising roughly $17 million, which is the maximum amount to be raised, the Sand Diego biotech company said.

Inovio Coronavirus Vaccine To Enter Mid-To-Late Stage Testing In September

Inovio Pharmaceuticals Inc (NASDAQ: INO) said during the earnings call Monday it expected its COVID-19 vaccine to enter mid-to-late stage human trials in September, Reuters

Regeneron Says Its Coronavirus Antibody Cocktail Shows Promise For Both Prevention, Treatment In Animal Testing

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) said Monday that a non-peer-reviewed study indicated its antibody drug combination both prevented and treated COVID-19 in animals, as earlier

Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development

Moderna Inc. (NASDAQ: MRNA) announced Sunday it is receiving another $472 million funding from President Donald Trump's administration to suppo

Johnson & Johnson Says Late-Stage Coronavirus Vaccine Trials Moved Ahead To September

Johnson & Johnson (NYSE: JNJ) said Thursday it would begin late-stage human trials for its COVID-19 vaccine ahead of schedule in September, with the phase one trials involving 1,000 people set to begin next week.

Omeros Shares Fall Over 40% On Renal Disease Trial Results

Global Market for DNA Sequencing Worth $1.7 Billion by 2013

Clinical Trial Recruitment Strategies - Optimizing patient recruitment

Conference on Clinical Trials Asia Summit 2010